F&V Capital Management LLC Has $10.65 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

F&V Capital Management LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS) by 1.2% in the first quarter, Holdings Channel reports. The institutional investor owned 133,539 shares of the pharmacy operator’s stock after acquiring an additional 1,590 shares during the period. CVS Health makes up 3.1% of F&V Capital Management LLC’s investment portfolio, making the stock its 13th largest holding. F&V Capital Management LLC’s holdings in CVS Health were worth $10,651,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atticus Wealth Management LLC increased its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. USA Financial Formulas raised its position in CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares during the last quarter. Ables Iannone Moore & Associates Inc. bought a new position in CVS Health during the 4th quarter valued at $32,000. Creekmur Asset Management LLC purchased a new position in CVS Health during the 4th quarter worth $34,000. Finally, Steph & Co. raised its holdings in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. SVB Leerink reaffirmed a “market perform” rating and issued a $60.00 price objective (down from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Baird R W raised CVS Health to a “hold” rating in a research report on Thursday, May 30th. Truist Financial reissued a “buy” rating and issued a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Finally, JPMorgan Chase & Co. cut their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Eleven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $75.05.

CVS Health Price Performance

NYSE CVS traded up $0.19 during trading hours on Wednesday, hitting $60.63. The company had a trading volume of 8,197,643 shares, compared to its average volume of 12,049,123. The firm has a 50 day simple moving average of $60.16 and a 200 day simple moving average of $70.45. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The firm has a market capitalization of $76.11 billion, a price-to-earnings ratio of 10.66, a PEG ratio of 0.58 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period last year, the company posted $2.20 EPS. Equities research analysts expect that CVS Health Co. will post 7.02 earnings per share for the current year.

Insider Buying and Selling at CVS Health

In related news, Director Edward J. Ludwig acquired 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.24% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.